Altimmune, Inc.
Public company- Headquarters
- MORRISTOWN, New Jersey
- Ticker
- ALT
- CIK
- 0001326190
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorPeter Greenleaf | Oct 27, 2026 | Appointed |
| Vice President, Global Controller and Principal Accounting OfficerRichard Menziuso | Sep 29, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- ELITE PHARMACEUTICALS INC /NV/
Class I director appointed: John W. LaRocca, Esq.
- Executive appointment
director appointed: Peter Greenleaf
Peter Greenleaf was named director of Altimmune, Inc., effective November 2, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 27, 2026Role: director
- Executive appointment
director appointed: Alex Howarth
Alex Howarth was named director of Altimmune, Inc., effective November 2, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 27, 2026Role: director
- Executive departure
director departs: Mitchell Sayare
Mitchell Sayare, director of Altimmune, Inc., retires the role. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 27, 2026Role: director
- Executive appointment
Vice President, Global Controller and Principal Accounting Officer appointed: Richard Menziuso
Richard Menziuso was named Vice President, Global Controller and Principal Accounting Officer of Altimmune, Inc., effective September 29, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 29, 2026Role: Vice President, Global Controller and Principal Accounting Officer
Last verified Nov 8, 2026